Dynamic alterations of ctDNA associate with the therapeutic outcome in the advanced non-small cell lung cancer patients who received sintilimab plus anlotinib regime as 1st line therapy.
Tianqing ChuJie YuanJun LuWei NieRunbo ZhongBao-Hui HanWei ZhangChunlei ShiJialin QianYanwei ZhangXueyan ZhangJiajun TengZhiqiang GaoYuqing LouJiaqi LiHuiping QiangChao ZhangJin LiXuefeng XiaHua ZhongBaohui HanPublished in: Clinical and translational medicine (2023)